Importantly, our in vitro findings on IFN-β induced downregulation of endothelial junction proteins and reduction of barrier integrity match the in vivo observation of increased IFN-β in the AD mouse model being correlated with increased brain endothelial barrier permeability. The gene discussed is IFNB1; the disease is Alzheimer disease.